| Literature DB >> 32524998 |
Erica Novo1, Claudia Bocca1, Beatrice Foglia1, Francesca Protopapa1, Marina Maggiora1, Maurizio Parola2, Stefania Cannito1.
Abstract
Liver fibrogenesis is defined as a dynamic and highly integrated process occurring during chronic injury to liver parenchyma that can result in excess deposition of extracellular matrix (ECM) components (i.e., liver fibrosis). Liver fibrogenesis, together with chronic inflammatory response, is then primarily involved in the progression of chronic liver diseases (CLD) irrespective of the specific etiology. In the present review we will first offer a synthetic and updated overview of major basic concepts in relation to the role of myofibroblasts (MFs), macrophages and other hepatic cell populations involved in CLD to then offer an overview of established and emerging issues and mechanisms that have been proposed to favor and/or promote CLD progression. A special focus will be dedicated to selected issues that include emerging features in the field of cholangiopathies, the emerging role of genetic and epigenetic factors as well as of hypoxia, hypoxia-inducible factors (HIFs) and related mediators.Entities:
Keywords: Cholangiopaties; Genetic factors; Hypoxia-inducible factors; Liver fibrogenesis; Macrophages; Myofibroblasts
Year: 2020 PMID: 32524998 DOI: 10.1016/j.abb.2020.108445
Source DB: PubMed Journal: Arch Biochem Biophys ISSN: 0003-9861 Impact factor: 4.013